News Vir Biotechnology, Inc.

Equities

VIR

US92764N1028

Market Closed - Nasdaq Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
10.27 ^USD	-1.15%		-2.65%	+2.09%

29/05	Vir Biotechnology, Inc. Appoints Mark D. Eisner as Executive Vice President and Chief Medical Officer, Effective June 3, 2024	CI
15/05	Transcript : Vir Biotechnology, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	30/05	BU
Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer	29/05	BU
Vir Biotechnology, Inc. Appoints Mark D. Eisner as Executive Vice President and Chief Medical Officer, Effective June 3, 2024	29/05	CI
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders	24/05	BU
Multiple Abstracts highlighting Vir Biotechnology's Latest Hepatitis Delta and B Data Accepted for Presentation at the EASL Congress 2024	23/05	AQ
Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024	22/05	BU
Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024	21/05	BU
Transcript : Vir Biotechnology, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM	15/05
Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024	03/05
Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M	03/05	MT
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results	03/05	BU
Vir Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024	01/05	BU
Cytokinetics Appoints Sung Lee as CFO	27/04	MT
Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024	18/04	CI
Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Executive Vice President, effective May 3, 2024	18/04	CI
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors	18/04	BU
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024	12/04	BU
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25/03	AQ
Transcript : Vir Biotechnology, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM	13/03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vir Biotechnology, Inc.

Equities

VIR

US92764N1028

Summary

Filters